Study drug compliance
| Subjects | Proportion of capsules used | ||
| <80% | >80% | ||
| OligoG–placebo | |||
| Period 1: OligoG | 32 | 6 (19) | 26 (81) |
| Period 2: placebo | 28 | 6 (21) | 22 (79) |
| Placebo–OligoG | |||
| Period 1: placebo | 33 | 3 (9) | 30 (91) |
| Period 2: OligoG | 31 | 6 (19) | 25 (81) |
Data are presented as n or n (%).